Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Recent Emergence of Rhenium(I) Tricarbonyl Complexes as Photosensitisers for Cancer Therapy.

Tytuł :
Recent Emergence of Rhenium(I) Tricarbonyl Complexes as Photosensitisers for Cancer Therapy.
Autorzy :
Liew HS; School of Postgraduate Studies, International Medical University, Bukit Jalil, Kuala Lumpur 57000, Malaysia.
Mai CW; Centre for Cancer and Stem Cell Research, International Medical University, Bukit Jalil, Kuala Lumpur 57000, Malaysia.; School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur 57000, Malaysia.
Zulkefeli M; School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur 57000, Malaysia.
Madheswaran T; School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur 57000, Malaysia.
Kiew LV; Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.
Delsuc N; Laboratoire des Biomolécules, Département de Chimie, École Normale Supérieure, PSL University, Sorbonne Université, 75005 Paris, France.
Low ML; School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur 57000, Malaysia.
Pokaż więcej
Źródło :
Molecules (Basel, Switzerland) [Molecules] 2020 Sep 12; Vol. 25 (18). Date of Electronic Publication: 2020 Sep 12.
Typ publikacji :
Journal Article; Review
Język :
English
Imprint Name(s) :
Original Publication: Basel, Switzerland : MDPI, c1995-
MeSH Terms :
Photochemotherapy*
Antineoplastic Agents/*pharmacology
Carbon/*chemistry
Neoplasms/*drug therapy
Photosensitizing Agents/*pharmacology
Rhenium/*chemistry
Animals ; Cell Line, Tumor ; Coordination Complexes/chemistry ; Drug Combinations ; Humans ; Mice ; Oxygen/chemistry ; Photons ; Photosensitizing Agents/chemistry ; Reactive Oxygen Species/chemistry
References :
Cell Mol Life Sci. 2009 Jul;66(14):2275-83. (PMID: 19333552)
Chemistry. 2014 Oct 27;20(44):14421-36. (PMID: 25213439)
Photochem Photobiol. 2005 Sep-Oct;81(5):1161-7. (PMID: 15934792)
Chemistry. 2017 Jul 21;23(41):9888-9896. (PMID: 28509422)
J Am Chem Soc. 2017 Oct 11;139(40):14302-14314. (PMID: 28948792)
ChemMedChem. 2014 Jun;9(6):1231-7. (PMID: 24678041)
Invest New Drugs. 2015 Feb;33(1):201-14. (PMID: 25344453)
ACS Chem Biol. 2014 Oct 17;9(10):2180-93. (PMID: 25137157)
Biomacromolecules. 2015 Jan 12;16(1):1-27. (PMID: 25426779)
J Colloid Interface Sci. 2018 Feb 1;511:325-334. (PMID: 29031152)
Cancer Res. 2003 Apr 15;63(8):1806-13. (PMID: 12702566)
Biomaterials. 2017 Jan;112:234-247. (PMID: 27768976)
J Natl Cancer Inst. 1998 Jun 17;90(12):889-905. (PMID: 9637138)
J Phys Chem A. 2009 Jul 16;113(28):8027-37. (PMID: 19545111)
Photochem Photobiol. 1987 Dec;46(6):1023-5. (PMID: 2964039)
Chem Commun (Camb). 2007 Aug 7;(29):3066-8. (PMID: 17639143)
Drug Des Devel Ther. 2015 Jul 24;9:3767-77. (PMID: 26244011)
Photochem Photobiol. 1998 Jan;67(1):140-9. (PMID: 9477772)
Acc Chem Res. 2017 Nov 21;50(11):2727-2736. (PMID: 29058879)
Chemistry. 2014 Feb 24;20(9):2496-507. (PMID: 24464824)
Int J Pharm. 2017 Jun 30;526(1-2):474-495. (PMID: 28501439)
Dalton Trans. 2017 Oct 31;46(42):14523-14536. (PMID: 28164201)
ACS Nano. 2011 Jun 28;5(6):5202-13. (PMID: 21627074)
Anticancer Res. 2016 Nov;36(11):6051-6057. (PMID: 27793932)
Radiat Res. 1998 Nov;150(5 Suppl):S146-56. (PMID: 9806617)
Curr Opin Ophthalmol. 1999 Jun;10(3):217-20. (PMID: 10537782)
Dalton Trans. 2014 Mar 21;43(11):4287-94. (PMID: 23982882)
Dalton Trans. 2018 Jul 31;47(30):9934-9974. (PMID: 29904760)
Chemistry. 2019 Jul 5;25(38):8970-8974. (PMID: 30901122)
Chem Rev. 2010 May 12;110(5):2795-838. (PMID: 20353192)
Angew Chem Int Ed Engl. 2015 Nov 16;54(47):14049-52. (PMID: 26447888)
Dalton Trans. 2019 Mar 26;48(13):4398-4404. (PMID: 30864598)
Lasers Med Sci. 1997 Oct;12(3):182-99. (PMID: 20803326)
Photodiagnosis Photodyn Ther. 2019 Dec;28:88-97. (PMID: 31454716)
Nat Rev Cancer. 2006 Jul;6(7):535-45. (PMID: 16794636)
J Photochem Photobiol B. 2009 Jul 17;96(1):1-8. (PMID: 19406659)
Chembiochem. 2020 Aug 3;21(15):2111-2115. (PMID: 32196894)
CA Cancer J Clin. 2020 Jan;70(1):7-30. (PMID: 31912902)
Chem Soc Rev. 2011 May;40(5):2508-24. (PMID: 21253643)
Colloids Surf B Biointerfaces. 2018 Jan 1;161:365-374. (PMID: 29101882)
Biomacromolecules. 2017 Nov 13;18(11):3506-3513. (PMID: 28806059)
Org Biomol Chem. 2009 Mar 7;7(5):897-904. (PMID: 19225672)
Lasers Surg Med. 2014 Aug;46(6):456-61. (PMID: 24799181)
Photodiagnosis Photodyn Ther. 2004 Dec;1(4):279-93. (PMID: 25048432)
Int J Mol Sci. 2015 Oct 23;16(10):25466-75. (PMID: 26512656)
J Biophotonics. 2018 Feb;11(2):. (PMID: 28858435)
Arch Ophthalmol. 2000 Mar;118(3):327-36. (PMID: 10721954)
Prog Tumor Res. 2014;41:62-77. (PMID: 24727987)
Int J Pharm. 2013 Sep 15;454(1):74-81. (PMID: 23834828)
Chem Commun (Camb). 2017 Nov 30;53(96):12857-12877. (PMID: 29115314)
Science. 2012 Nov 16;338(6109):903-10. (PMID: 23161990)
Postepy Biochem. 2013;59(1):53-63. (PMID: 23821943)
J Natl Cancer Inst. 1997 Jan 15;89(2):112-4. (PMID: 8998175)
Photochem Photobiol. 2003 Sep;78(3):271-7. (PMID: 14556314)
Biochem J. 2016 Feb 15;473(4):347-64. (PMID: 26862179)
Medicina (Kaunas). 2003;39(12):1137-50. (PMID: 14704501)
Curr Med Chem. 2008;15(17):1655-73. (PMID: 18673216)
Photochem Photobiol. 2009 Sep-Oct;85(5):1053-74. (PMID: 19682322)
Chem Soc Rev. 2017 Oct 2;46(19):5771-5804. (PMID: 28654103)
Anticancer Res. 2016 Nov;36(11):5813-5819. (PMID: 27793903)
Lasers Surg Med. 1995;16(4):359-67. (PMID: 7651057)
J Clin Oncol. 2010 Feb 20;28(6):928-35. (PMID: 20065181)
Eur J Inorg Chem. 2014 Feb 1;2014(5):807-811. (PMID: 25050081)
Adv Drug Deliv Rev. 2010 Mar 8;62(3):339-45. (PMID: 19909777)
Biomed Pharmacother. 2018 Oct;106:1098-1107. (PMID: 30119176)
Photodiagnosis Photodyn Ther. 2007 Mar;4(1):3-11. (PMID: 25047184)
Cancers (Basel). 2017 Dec 19;9(12):. (PMID: 29257070)
Chem Commun (Camb). 2013 Feb 14;49(13):1294-6. (PMID: 23295243)
Invest New Drugs. 2015 Aug;33(4):848-60. (PMID: 26108551)
Org Biomol Chem. 2009 Mar 7;7(5):889-96. (PMID: 19225671)
Crit Rev Oncol Hematol. 2001 Jul-Aug;39(1-2):99-106. (PMID: 11418306)
Ann Transl Med. 2017 Apr;5(8):183. (PMID: 28616398)
Clin Endosc. 2013 Jan;46(1):7-23. (PMID: 23423543)
ACS Nano. 2013 Jul 23;7(7):5858-69. (PMID: 23734880)
Coord Chem Rev. 2015 Jan 1;282-283:110-126. (PMID: 25729089)
Chem Commun (Camb). 2010 Jan 14;46(2):186-202. (PMID: 20024327)
Int Rev Immunol. 2015 Mar;34(2):101-3. (PMID: 25901856)
Acta Pharm Sin B. 2018 Mar;8(2):137-146. (PMID: 29719775)
Angew Chem Int Ed Engl. 2016 Oct 17;55(43):13538-13543. (PMID: 27529470)
Chem Rev. 2019 Jan 23;119(2):797-828. (PMID: 30295467)
World J Gastroenterol. 2012 Sep 21;18(35):4944-58. (PMID: 23002368)
Chem Soc Rev. 2016 Dec 21;45(24):6725-6741. (PMID: 27711672)
Photodiagnosis Photodyn Ther. 2010 Jun;7(2):61-75. (PMID: 20510301)
Photodiagnosis Photodyn Ther. 2013 Sep;10(3):296-303. (PMID: 23993856)
Curr Opin Chem Biol. 2020 Jun;56:23-27. (PMID: 31759225)
J Med Chem. 2006 Apr 6;49(7):2276-83. (PMID: 16570924)
J Photochem Photobiol B. 2019 Oct;199:111598. (PMID: 31465971)
Chem Soc Rev. 2014 Jul 7;43(13):4778-823. (PMID: 24733589)
Chem Commun (Camb). 2019 Sep 17;55(75):11235-11238. (PMID: 31469153)
J Clin Oncol. 2010 May 1;28(13):2181-90. (PMID: 20351327)
Methods Enzymol. 2007;435:297-321. (PMID: 17998060)
Semin Nucl Med. 2008 Mar;38(2):S19-29. (PMID: 18243839)
Clin Dermatol. 2006 Jan-Feb;24(1):16-25. (PMID: 16427502)
J Thorac Cardiovasc Surg. 2010 Aug;140(2):377-86. (PMID: 20400121)
Expert Opin Pharmacother. 2001 Feb;2(2):351-61. (PMID: 11336591)
Cancer Chemother Pharmacol. 2006 Jan;57(1):40-5. (PMID: 16001178)
Photochem Photobiol. 2003 Apr;77(4):431-9. (PMID: 12733655)
Curr Drug Metab. 2009 Oct;10(8):836-41. (PMID: 20214578)
Photochem Photobiol. 2001 Nov;74(5):656-69. (PMID: 11723793)
Nanoscale. 2014;6(3):1567-72. (PMID: 24326457)
ChemMedChem. 2013 Jun;8(6):924-7. (PMID: 23568508)
Gut. 2002 Apr;50(4):549-57. (PMID: 11889078)
Lancet Oncol. 2004 Aug;5(8):497-508. (PMID: 15288239)
Lancet Oncol. 2013 Oct;14(11):e476-e485. (PMID: 24079875)
Anticancer Agents Med Chem. 2008 Apr;8(3):269-79. (PMID: 18393786)
ACS Appl Mater Interfaces. 2014 May 14;6(9):6469-80. (PMID: 24780315)
P T. 2017 Aug;42(8):514-521. (PMID: 28781505)
Lasers Med Sci. 2008 Jul;23(3):217-28. (PMID: 17674122)
Chem Commun (Camb). 2010 Sep 14;46(34):6255-7. (PMID: 20668778)
Br J Pharmacol. 2008 May;154(1):1-3. (PMID: 18362894)
Chem Commun (Camb). 2018 Jan 18;54(7):715-718. (PMID: 29231936)
Chem Sci. 2015 May 1;6(5):2660-2686. (PMID: 29308166)
Sykepleien. 1968 Jul 15;55(15):412. (PMID: 5188123)
Int J Nanomedicine. 2017 Sep 05;12:6487-6502. (PMID: 28919750)
Nat Rev Clin Oncol. 2019 Jan;16(1):11-26. (PMID: 30341417)
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1352-8. (PMID: 20638194)
Int J Hyperthermia. 2015;31(5):476-88. (PMID: 25974074)
Invest New Drugs. 2019 Oct;37(5):973-983. (PMID: 30632005)
Photomed Laser Surg. 2013 Aug;31(8):398-407. (PMID: 23859750)
Neuro Oncol. 2012 Apr;14(4):416-25. (PMID: 22427110)
Photochem Photobiol Sci. 2005 Jan;4(1):113-8. (PMID: 15616701)
Int J Pharm. 2012 Apr 15;426(1-2):193-201. (PMID: 22274587)
Chem Commun (Camb). 2018 Nov 20;54(93):13040-13059. (PMID: 30398487)
Photochem Photobiol. 2006 Mar-Apr;82(2):527-37. (PMID: 16613509)
Lasers Surg Med. 2006 Jun;38(5):427-34. (PMID: 16788929)
Adv Drug Deliv Rev. 2008 Dec 14;60(15):1627-37. (PMID: 18930086)
Contributed Indexing :
Keywords: cancer; medicinal inorganic chemistry; metals in medicine; photodynamic therapy; photosensitisers; rhenium(I) tricarbonyl complexes
Substance Nomenclature :
0 (Antineoplastic Agents)
0 (Coordination Complexes)
0 (Drug Combinations)
0 (Photosensitizing Agents)
0 (Reactive Oxygen Species)
7440-15-5 (Rhenium)
7440-44-0 (Carbon)
S88TT14065 (Oxygen)
Entry Date(s) :
Date Created: 20200916 Date Completed: 20210406 Latest Revision: 20210406
Update Code :
20210407
PubMed Central ID :
PMC7571230
DOI :
10.3390/molecules25184176
PMID :
32932573
Czasopismo naukowe
Photodynamic therapy (PDT) is emerging as a significant complementary or alternative approach for cancer treatment. PDT drugs act as photosensitisers, which upon using appropriate wavelength light and in the presence of molecular oxygen, can lead to cell death. Herein, we reviewed the general characteristics of the different generation of photosensitisers. We also outlined the emergence of rhenium (Re) and more specifically, Re(I) tricarbonyl complexes as a new generation of metal-based photosensitisers for photodynamic therapy that are of great interest in multidisciplinary research. The photophysical properties and structures of Re(I) complexes discussed in this review are summarised to determine basic features and similarities among the structures that are important for their phototoxic activity and future investigations. We further examined the in vitro and in vivo efficacies of the Re(I) complexes that have been synthesised for anticancer purposes. We also discussed Re(I) complexes in conjunction with the advancement of two-photon PDT, drug combination study, nanomedicine, and photothermal therapy to overcome the limitation of such complexes, which generally absorb short wavelengths.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies